Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APC-111 vs Penicillin VK for Strep Pharyngitis
NCT00242281Phase 3Completed
- Sponsor
- Advancis Pharmaceuticals
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of amoxicillin in streptococcal pharyngitis (2 arms), sponsored by Advancis Pharmaceuticals. Primary endpoint: Bacteriological outcome at the Test-of-Cure Visit. Started Nov 2005; status: completed.
02
Drugs
amoxicillin
03
Conditions
streptococcal pharyngitis
Beyond the preview
Go deeper on NCT00242281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242281.